MedTrace Logo

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse

NCT02361099 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2020-06-29

No results posted yet for this study

Summary

This is a study that evaluates an optimization of the monitoring of patients with lung cancer in order to extend the survival of patients by improving their quality of life and decreasing anxiety generated by the achievement of balance sheets imaging. The spacing of the follow-up imaging also helps to reduce the cost of such monitoring. The main objective of this study is to evaluate the overall survival of patients.

Conditions

Interventions

OTHER

Monitoring by SENTINEL application

Patients will connect once a week to SENTINEL application to do a self-evaluation of several symptoms. A CT- scan will be scheduled only when there is an alert of the application

Sponsors & Collaborators

  • Sivan Innovation Ltd.

    collaborator INDUSTRY

  • Weprom

    lead OTHER

Principal Investigators

  • Fabrice DENIS, MD · Centre Jean Bernard - LE MANS

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-03
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02361099 on ClinicalTrials.gov